These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 33819928)

  • 1. Inferring latent heterogeneity using many feature variables supervised by survival outcome.
    Jia B; Zeng D; Liao JJZ; Liu GF; Tan X; Diao G; Ibrahim JG
    Stat Med; 2021 Jun; 40(13):3181-3195. PubMed ID: 33819928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bayesian two-step Lasso strategy for biomarker selection in personalized medicine development for time-to-event endpoints.
    Gu X; Yin G; Lee JJ
    Contemp Clin Trials; 2013 Nov; 36(2):642-50. PubMed ID: 24075829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mixture survival trees for cancer risk classification.
    Jia B; Zeng D; Liao JJZ; Liu GF; Tan X; Diao G; Ibrahim JG
    Lifetime Data Anal; 2022 Jul; 28(3):356-379. PubMed ID: 35486260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inference on latent factor models for informative censoring.
    Ungolo F; van den Heuvel ER
    Stat Methods Med Res; 2022 May; 31(5):801-820. PubMed ID: 35077263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bayesian latent factor on image regression with nonignorable missing data.
    Wang X; Song X; Zhu H
    Stat Med; 2021 Feb; 40(4):920-932. PubMed ID: 33169396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subtype classification and heterogeneous prognosis model construction in precision medicine.
    You N; He S; Wang X; Zhu J; Zhang H
    Biometrics; 2018 Sep; 74(3):814-822. PubMed ID: 29359319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Favoring the hierarchical constraint in penalized survival models for randomized trials in precision medicine.
    Belhechmi S; Le Teuff G; De Bin R; Rotolo F; Michiels S
    BMC Bioinformatics; 2023 Mar; 24(1):96. PubMed ID: 36927444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bayesian adaptive lasso for additive hazard regression with current status data.
    Wang C; Li Q; Song X; Dong X
    Stat Med; 2019 Sep; 38(20):3703-3718. PubMed ID: 31197854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bayesian adaptive design of early-phase clinical trials for precision medicine based on cancer biomarkers.
    Yada S
    Int J Biostat; 2021 Jun; 18(1):109-125. PubMed ID: 34114385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Bayesian adaptive lasso regression.
    Alhamzawi R; Ali HTM
    Math Biosci; 2018 Sep; 303():75-82. PubMed ID: 29920251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure detection of semiparametric structural equation models with Bayesian adaptive group lasso.
    Feng XN; Wang GC; Wang YF; Song XY
    Stat Med; 2015 Apr; 34(9):1527-47. PubMed ID: 25640461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous estimation and variable selection in median regression using Lasso-type penalty.
    Xu J; Ying Z
    Ann Inst Stat Math; 2010 Jun; 62(3):487-514. PubMed ID: 23976790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk-group-specific dose finding based on an average toxicity score.
    Bekele BN; Li Y; Ji Y
    Biometrics; 2010 Jun; 66(2):541-8. PubMed ID: 19645698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Model selection in medical research: a simulation study comparing Bayesian model averaging and stepwise regression.
    Genell A; Nemes S; Steineck G; Dickman PW
    BMC Med Res Methodol; 2010 Dec; 10():108. PubMed ID: 21134252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scalable Bayesian variable selection for structured high-dimensional data.
    Chang C; Kundu S; Long Q
    Biometrics; 2018 Dec; 74(4):1372-1382. PubMed ID: 29738602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bayesian variable selection in linear quantile mixed models for longitudinal data with application to macular degeneration.
    Ji Y; Shi H
    PLoS One; 2020; 15(10):e0241197. PubMed ID: 33104698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bayesian Plackett-Luce Mixture Models for Partially Ranked Data.
    Mollica C; Tardella L
    Psychometrika; 2017 Jun; 82(2):442-458. PubMed ID: 27734294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New adaptive lasso approaches for variable selection in automated pharmacovigilance signal detection.
    Courtois É; Tubert-Bitter P; Ahmed I
    BMC Med Res Methodol; 2021 Dec; 21(1):271. PubMed ID: 34852782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A non-parametric Bayesian joint model for latent individual molecular profiles and survival in oncology.
    Rincourt SL; Michiels S; Drubay D
    J Bioinform Comput Biol; 2022 Oct; 20(5):2250022. PubMed ID: 36287465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Causal mediation analysis with latent subgroups.
    Wang W; Xu J; Schwartz J; Baccarelli A; Liu Z
    Stat Med; 2021 Nov; 40(25):5628-5641. PubMed ID: 34263963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.